Lipum Dirección

Dirección controles de criterios 1/4

El CEO de Lipum's es Ola Sandborgh, nombrado en Dec 2023, tiene una permanencia de menos de un año. posee directamente un 0.18% de las acciones de la empresa, con un valor de SEK322.49K. La antigüedad media del equipo directivo y de la junta directiva es de 0.6 años y 3 años, respectivamente.

Información clave

Ola Sandborgh

Chief Executive Officer (CEO)

n/a

Compensación total

Porcentaje del salario del CEO	n/a
Permanencia del CEO	less than a year
Participación del CEO	0.2%
Permanencia media de la dirección	less than a year
Promedio de permanencia en la Junta Directiva	3yrs

Actualizaciones recientes de la dirección

Recent updates

CEO

Ola Sandborgh (58 yo)

less than a year

Permanencia

Mr. Ola Sandborgh serves as CEO at Lipum AB (publ) since December 01, 2023. He has experience from the pharmaceutical industry where he has worked in leading roles in different commercial, innovation and b...

Equipo directivo

Nombre	Posición	Permanencia	Compensación	Propiedad
Olle Hernell	Co-Founder & Director	no data	SEK 303.50k	1.61% SEK 3.0m
Marina Norberg	Chief Financial Officer	3.5yrs	SEK 553.50k	0.077% SEK 145.1k
Ola Sandborgh	Chief Executive Officer	less than a year	sin datos	0.18% SEK 333.7k
Susanne Lindquist	Co-Founder & Head of Research (CSO)	no data	sin datos	1.53% SEK 2.9m
Pernilla Abrahamsson	Chief Operating Officer	no data	sin datos	0.034% SEK 63.4k
Karin Franck-Larsson	C.M.O.	less than a year	sin datos	sin datos

0.7yrs

Permanencia media

60yo

Promedio de edad

Equipo directivo experimentado: El equipo directivo de LIPUM no se considera experimentado ( 0.6 años antigüedad media), lo que sugiere un nuevo equipo.

Miembros de la Junta

Nombre	Posición	Permanencia	Compensación	Propiedad
Olle Hernell	Co-Founder & Director	no data	SEK 303.50k	1.61% SEK 3.0m
Gustav Kihlstrom	Independent Chairman of the Board	3.1yrs	sin datos	sin datos
Björn Löwenadler	Member of Scientific Advisory Board	no data	sin datos	sin datos
Carl-Johan Spak	Independent Director	1.2yrs	sin datos	0.017% SEK 31.2k
Anders Fasth	Member of Scientific Advisory Board	no data	sin datos	sin datos
Lennart Lundberg	Member of Scientific Advisory Board	3yrs	sin datos	sin datos
Asa Hansdotter	Independent Director	3.1yrs	sin datos	sin datos
Kristian Sandberg	Independent Director	4.3yrs	sin datos	sin datos
Rikard Holmdahl	Member of Scientific Advisory Board	no data	sin datos	sin datos
Solbritt Dahlqvist	Member of Scientific Advisory Board	no data	sin datos	sin datos
Asa Magnusson	Director	less than a year	sin datos	sin datos

3.0yrs

Permanencia media

69.5yo

Promedio de edad

Junta con experiencia: La junta directiva de LIPUM se considera experimentada (3 años de antigüedad promedio).

Lipum Dirección

Dirección controles de criterios 1/4

Información clave

Actualizaciones recientes de la dirección

High number of new directors

Lipum AB (publ) Announces Nomination Committee Appointments

Lipum AB (Publ) Appoints Ola Sandborgh as Chief Executive Officer, Effective from December 1, 2023

Lipum AB (Publ) Appoints Karin Franck-Larsson as CMO

Lipum Elects Carl-Johan Spak as New Board Member

Chief Executive Officer recently bought kr161k worth of stock

Recent updates

High number of new directors

Lipum AB (publ) Completes Multiple Dose Part of the Phase I Clinical Study

Lipum AB (publ) has completed a Follow-on Equity Offering in the amount of SEK 79.714945 million.

Lipum Recommends Shareholders to Not Accept Mandatory Cash Offer

Lipum Recommends Shareholders to Not Accept Mandatory Cash Offer

Forecast to breakeven in 2025

Lipum AB (publ) has filed a Follow-on Equity Offering.

Lipum AB (publ) has filed a Follow-on Equity Offering.

Lipum AB (publ) Reports Positive Interim Results from Clinical Phase 1 Study Showing that SOL-116 Reduces Plasma BSSL Levels in Healthy Subjects

Lipum AB (Publ) Receives Funding from Vinnova for an Eurostars Application

Lipum AB (publ) Announces Nomination Committee Appointments

Lipum AB (Publ) Appoints Ola Sandborgh as Chief Executive Officer, Effective from December 1, 2023

New major risk - Revenue and earnings growth

Lipum AB (Publ) Appoints Karin Franck-Larsson as CMO

New minor risk - Share price stability

New major risk - Revenue and earnings growth

Lipum Elects Carl-Johan Spak as New Board Member

Chief Executive Officer recently bought kr161k worth of stock

Lipum AB (publ) Announces the Nomination Committee for the 2023 Annual General Meeting

Chief Executive Officer recently bought kr157k worth of stock

Lipum AB (Publ) Has Initiated A Phase 1 Clinical Study with Its Drug Candidate Sol-116

Lipum AB (publ) announced that it has received SEK 38.999963 million in funding from Flerie Invest AB

Lipum AB (publ) Gets Approval to Start Phase 1 Clinical Trial with Drug Candidate Sol-116

Lipum AB (publ) Appoints Helena Bergström as Chief Medical Officer

Lipum Reports Completion of GLP Toxicology- and Safety Program on the Candidate Drug (SOL-116)

Chief Executive Officer recently bought kr195k worth of stock

Lipum AB (Publ) Reports Gmp Production of Sol-116 Successful

Lipum Recruits Fredrik Seijsing as Scientist

Lipum AB (publ) Initiates GMP-Production for Clinical Trials

Lipum Is At the Final Step Before Clinical Phase

CEO

Permanencia

Equipo directivo

Permanencia media

Promedio de edad

Miembros de la Junta

Permanencia media

Promedio de edad